These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35190681)

  • 1. Cancer treatment toxicity affects women more than men.
    O'Leary K
    Nat Med; 2022 Feb; ():. PubMed ID: 35190681
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma.
    Chansky K; Benedetti J; Macdonald JS
    Cancer; 2005 Mar; 103(6):1165-71. PubMed ID: 15693031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.
    Sloan JA; Goldberg RM; Sargent DJ; Vargas-Chanes D; Nair S; Cha SS; Novotny PJ; Poon MA; O'Connell MJ; Loprinzi CL
    J Clin Oncol; 2002 Mar; 20(6):1491-8. PubMed ID: 11896096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionation for clinically localized prostate cancer.
    Hickey BE; James ML; Daly T; Soh FY; Jeffery M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Toxicity and Outcomes in Clinical Trial Participants From Minority Populations.
    Labriola M; George DJ
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-5. PubMed ID: 33929878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
    Lee YC; Wang L; Kohn EC; Rubinstein L; Ivy SP; Harris PJ; Lheureux S
    Cancer; 2020 May; 126(10):2139-2145. PubMed ID: 32097505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for hormone-refractory prostate cancer.
    Shelley M; Harrison C; Coles B; Staffurth J; Wilt TJ; Mason MD
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005247. PubMed ID: 17054249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
    Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
    Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.
    Chamberlain RM; Winter KA; Vijayakumar S; Porter AT; Roach M; Streeter O; Cox JD; Bondy ML
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):9-15. PubMed ID: 9422552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.
    Hwang ME; Mayeda M; Liz M; Goode-Marshall B; Gonzalez L; Elliston CD; Spina CS; Padilla OA; Wenske S; Deutsch I
    Radiat Oncol; 2019 Aug; 14(1):136. PubMed ID: 31375119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sex on toxicity and treatment outcome in small-cell lung cancer.
    Singh S; Parulekar W; Murray N; Feld R; Evans WK; Tu D; Shepherd FA
    J Clin Oncol; 2005 Feb; 23(4):850-6. PubMed ID: 15681530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
    Wheatley-Price P; Le Maître A; Ding K; Leighl N; Hirsh V; Seymour L; Bezjak A; Shepherd FA;
    J Thorac Oncol; 2010 May; 5(5):640-8. PubMed ID: 20354457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.
    Wheatley-Price P; Ma C; Ashcroft LF; Nankivell M; Stephens RJ; White SC; Lorigan P; Thatcher N; Blackhall FH; Shepherd FA
    Ann Oncol; 2010 Feb; 21(2):232-237. PubMed ID: 19675093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Goel S; Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort.
    Brioli A; Nägler TM; Yomade O; Rüthrich MM; Scholl S; Frietsch JJ; Hilgendorf I; Ernst T; Sayer HG; Hochhaus A; Mügge LO; von Lilienfeld-Toal M
    Oncol Res Treat; 2022; 45(9):494-503. PubMed ID: 35705004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.
    RAINBO Research Consortium
    Int J Gynecol Cancer; 2022 Dec; 33(1):109-17. PubMed ID: 36600534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
    Nair B; Wilt T; MacDonald R; Rutks I
    Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.